Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Risk Profiles in AMD: What to tell Patients?

Hense H.-W.
Westfälische Wilhelms-Universität Münster, Institut für Epidemiologie und Sozialmedizin, Münster

Purpose: Progressive age related macular degeneration (AMD) leads to loss of vision. Therapeutic options are limited and can in most instances only delay visual deterioration. Promising aspects of primary and secondary prevention are of great relevance to patients and doctors alike.
Method: Review of available evidence from epidemiologic and interventional studies identifying patient profiles that are related to increased risk or protection of AMD.
Results: Strongest risk factor in epidemiologic studies is past and current smoking. The evidence for occupational or leisure time exposure to light is inconsistent, probably as a consequence of methodological problems with exposure ascertainment. High relevance is presently assigned to antioxidants including macular pigment. Here again, the epidemiologic evidence is inconsistent and methodological differences of studies are substantial. The recently completed AREDS study has shown in a randomised, controlled design that application of antioxidants plus zinc reduces the progression rate from the early to the late stages of AMD. Another randomised study, investigating the impact of vitamin E supplementation, was unable to report any protective effects. Finally, the hypothesis that lipid lowering drugs such as statins have a protective effect on AMD was not confirmed when tested in a well-designed prospective study.
Conclusions: To date


Zurück | Back